Gona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare 

Shots  United Imaging is advancing the future of radiology through the convergence of ultra-high-field imaging and AI, with the uMR Jupiter 5T enabling unprecedented anatomical and functional visualization while next-generation AI transforms imaging data into actionable clinical insights that support earlier diagnosis, precision medicine, and personalized patient care.  At HLTH Europe 2026, the company highlighted how 5T whole-body MRI expands clinical capabilities across vascular imaging, neuroimaging, and oncology by delivering higher signal-to-noise ratio, enhanced spatial resolution, and advanced metabolic imaging, enabling clinicians to detect subtle disease earlier, characterize lesions with greater confidence, and improve treatment planning.  PharmaShots welcomes Gona Aziz, who shares her perspectives on the evolving role of AI in radiology, the importance of lifecycle-based AI regulation, clinician and patient collaboration, overcoming implementation barriers, and how the convergence of ultra-high-field MRI and AI will redefine diagnostic imaging, predictive care, and healthcare innovation over the next five years.  Aditya: At HLTH Europe, United Imaging is highlighting the uMR Jupiter 5T and discussing the future of AI-enabled radiology. How do you see advanced imaging technologies and AI evolving together to reshape diagnostic decision-making?  Gona: We see advanced imaging and AI evolving as two sides of the same transformation. Technologies like the uMR Jupiter 5T enable clinicians to capture previously unseen levels of anatomical and functional detail, while AI helps turn that information into actionable insights. At HLTH Europe, we discussed how the next generation of AI is moving beyond single-disease algorithms toward multimodal systems that can see, reason, and explain their findings within the clinical workflow. Together, ultra-high-field imaging and AI can help radiologists move from simply detecting abnormalities to understanding disease earlier, monitoring change over time, and supporting more personalized, data-driven care. Ultimately, the goal is not to replace clinical expertise, but to give clinicians more confidence, context, and precision in their decision-making.  Aditya: The uMR Jupiter 5T brings ultra-high-resolution, whole-body MRI into clinical practice. What new clinical insights or diagnostic capabilities become possible with 5T imaging that were previously difficult to achieve with conventional MRI systems?  Gona: The uMR Jupiter 5T brings ultra-high-field MRI into whole-body clinical imaging, with particular value in vascular imaging, focused organ imaging, and neuroimaging. By delivering a higher signal-to-noise ratio, higher spatial resolution, and stronger contrast, which are enhanced by prolonged T1 and susceptibility effects, 5T enables clinicians to see details that were previously difficult to capture with conventional MRI.  For example, higher-resolution vessel wall imaging may help identify the true culprit lesion responsible for ischemic stroke, rather than only showing the downstream blocked vessel. In organs such as the liver and prostate, higher in-plane resolution and thinner slices can support more accurate visualization of tumor boundaries, which is important for diagnosis, treatment planning, and follow-up. In neuroimaging, the increased sensitivity to susceptibility changes can significantly improve the detection of cerebral microbleeds and imaging features related to Parkinson’s disease. Beyond anatomy, 5T also enables advanced applications such as MR spectroscopy, metabolic imaging (including CEST), and multinuclear imaging, where improved signal can translate into higher resolution or more robust clinical data.  In this sense, 5T is not only about sharper images. It expands the clinical information MRI can provide, helping clinicians detect subtle disease earlier, characterize lesions more confidently, and gain deeper insight into complex conditions across the body.  Aditya: During your workshop, one of the key themes is the growing gap between the pace of AI innovation and regulatory approval. From your perspective, what changes are needed to ensure patients and clinicians can benefit from innovation without compromising safety and trust?  Gona: The biggest shift is moving from a one-time approval mindset to a lifecycle approach. AI is evolving continuously, so regulation must support ongoing validation, monitoring, and rapid but responsible updates. At the same time, transparency is critical. Clinicians need to understand not just the output, but the reasoning behind it, which is why explainable and interpretable AI is becoming so important.  Moreover, the regulatory pathway should be set up to expedite access to clinical AI solutions; this would support clinicians and benefit patients. Patients should be stakeholders in this journey. It is important to involve patients in shaping AI solutions, giving them a better understanding of how AI can contribute to better clinical outcomes.  The active involvement of both clinicians and patients in the development of AI Solutions is a must. Ultimately, faster regulation only works if it goes hand in hand with transparency and patient trust.   Aditya: As AI becomes increasingly integrated into radiology workflows, what are the biggest barriers healthcare systems face when moving from pilot projects to routine clinical implementation?  Gona: Technology is no longer the main barrier, but adoption is. Healthcare organizations need governance frameworks, workflow integration, staff training, and continuous performance monitoring. Clinicians must trust that AI fits naturally into their workflow and delivers measurable clinical and operational value.  Aditya: The radiology community is generating vast amounts of imaging data. How can advanced imaging platforms and AI work together to unlock greater value from that data while supporting more personalized patient care?  Gona: The real opportunity is transforming imaging data into actionable intelligence. Advanced imaging systems like the uMR Jupiter 5T generate unprecedented levels of anatomical and functional detail, while AI helps identify patterns, quantify change over time, and support earlier, more personalized decisions. The future is not just detecting findings; it is understanding patient trajectories and guiding care across the entire patient journey.  Aditya: Collaboration between clinicians, industry leaders, and regulators is a central topic of your HLTH Europe discussion. What does successful collaboration look like in practice, and how can stakeholders work together to accelerate responsible AI adoption in radiology?  Gona: Successful collaboration starts with co-development. Rather than building AI in isolation, industry, clinicians, regulators, and healthcare providers need to work together from design through deployment. Similarly, AI can contribute to scientific research, providing an efficient tool to university hospitals and research institutions. When clinical needs, research, regulatory requirements, and real-world workflow feedback are aligned early, innovation reaches patients faster and more safely.  Aditya: Looking ahead, what do you believe will be the most transformative development in imaging and radiology over the next five years; ultra-high-field MRI, AI-driven diagnostics, or the convergence of both technologies?  Gona: The biggest transformation will come from the convergence of ultra-high-field imaging and AI. Systems like the uMR Jupiter 5T enable clinicians to “see the unseen” with exceptional resolution, while AI helps interpret that information, automate workflows, and reveal insights that support precision medicine. Together, they can move imaging beyond diagnosis toward prediction, monitoring, and truly personalized care.  About Gona Aziz  Gona Aziz is the Head of Marketing and Communication with nearly two decades of experience driving strategic marketing, product management, and commercial growth across healthcare, software, and technology sectors. A people-centric and results-driven leader, she has successfully led cross-functional teams through organizational transformation while delivering impactful campaigns, events, and go-to-market strategies that accelerate business growth. Passionate about healthcare innovation, Gona has extensive expertise in innovation commercialization, international collaborations, and patient-centered care, with a proven track record of translating research into market-ready solutions. Her leadership combines strategic vision with a strong focus on building high-performing teams, advancing healthcare transformation, and strengthening brand value.   The post Gona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare  appeared first on PharmaShots.